Benchmark
OncoTraj Benchmark
What is OncoTraj?
OncoTraj is a public benchmark for predicting acquired resistance to first-line osimertinib in EGFR-mutant non-small-cell lung cancer. It provides a harmonized…
- Released
- 2026-06-09
- Evaluates
- Biology & Drug Discovery, Language & Knowledge, cs.LG
- Openness
- unknown
- Importer
- Claire Radar
- Review status
- unreviewed
- Reported scores
- 0
Source provenance
- Original evidence https://arxiv.org/abs/2606.11144
OncoTraj paper, code and dataset
No reported scores are on record for this benchmark yet.